Japer Therapeutics Warrants
JSPRW
9 hedge funds and large institutions have $761K invested in Japer Therapeutics Warrants in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
13% more funds holding
Funds holding: 8 → 9 (+1)
30% less capital invested
Capital invested by funds: $1.09M → $761K (-$331K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$4.38K |
| 2 |
VF
Virtu Financial
New York
|
+$1.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$40.6K |
| 2 |
Walleye Trading
New York
|
-$2.72K |
| 3 |
CS
Clear Street
New York
|
-$2 |
JSPRW Hedge Fund Activity: Q4 2025 in Review
9 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q4 2025, worth a combined $761K — down 30% from $1.09M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new JSPRW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Toronto Dominion Bank, adding an estimated $4.38K. The largest seller was Walleye Capital, cutting an estimated $40.6K.
- 9 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q4 2025, up from 8 in Q3 2025.
- Funds reported $761K of Japer Therapeutics Warrants stock for Q4 2025, down 30% quarter-over-quarter.
- 2 funds opened new Japer Therapeutics Warrants positions in Q4 2025 and 1 closed out, a net change of +1 holder.
- The largest Japer Therapeutics Warrants buyer in Q4 2025 was Toronto Dominion Bank, an estimated $4.38K added.
- The largest Japer Therapeutics Warrants seller in Q4 2025 was Walleye Capital, an estimated $40.6K sold.
Based on aggregated 13F filings for Q4 2025.